HealthEdge Completes Investment in Santus
TAMPA, FLORIDA – June 4, 2015 – HealthEdge Investment Partners (“HealthEdge”) announced that Santus, LLC (“Santus” or the “Company”), owned jointly with Ambassador Enterprises (“Ambassador”), has acquired substantially all the healthcare assets from Summit Industries, Inc. (“Summit”), primarily consisting of the Lantiseptic® and Boroleum® brands (the “brands”). Santus was formed in 2015 simultaneous with the acquisition and is the sixth portfolio company in HealthEdge Investment Fund II.
The Lantiseptic brand includes a line of lanolin-based, over-the-counter monographed products differentiated into four therapeutic applications—cleansing, moisturizing, protection, and treatment. Lantiseptic has been a leader in the skin care category for hospitals, long-term care facilities, and nursing homes since its introduction in 1984, and along with Boroleum, is used to prevent and treat a wide variety of skin conditions.
The acquisition of these brands is the first for Santus, which was formed by HealthEdge to build a company focused on consumer healthcare, wellness, and medical products. This investment provides Santus an opportunity to drive growth by bringing together the proven track record of HealthEdge appointed President and CEO Terry Conrad along with HealthEdge’s industry knowledge, experience, and network.
“It’s exciting to join the Santus team and be given the opportunity to build an attractive specialty health care business. HealthEdge is tremendously skilled at building businesses and creating value, and I look forward to working with the board to build a strong health care franchise that will make a difference in the lives of the patients and customers we serve,” said Santus’ President and CEO Terry Conrad.
HealthEdge Partner Jeff Thompson said, “We are pleased to add Santus to our portfolio and have the opportunity to partner with a like-minded organization like Ambassador. The HealthEdge team has broad and relevant experience with products companies in this space, and this investment is a terrific strategic fit for our firm. ”
Matt Dawson, HealthEdge VP and CFO, added, “This acquisition provides Santus a brand that has forged a strong reputation in its industry for over three decades. We are excited for the future of the Santus-owned brands and our pursuit of an aggressive growth strategy, which will include organic brand growth and add-on acquisitions for expansion into complementary product offerings.”
Santus is a healthcare products company headquartered in Tampa, FL. The flagship products are Lantiseptic, an over-the-counter skin care line, and Boroleum, an analgesic ointment for relief of a wide variety of nasal and facial discomforts. For more information on Santus, please visit www.lantiseptic.com.
About Ambassador Enterprises
Established in 2008, Ambassador Enterprises is a for-profit, philanthropic, equity firm investing to optimize leaders and the organizations they lead. Ambassador believes that strategically investing in people and teams will provide returns in the form of healthy relationships, vibrant communities, and value creation. Included among Ambassador’s valued partners are academic institutions, businesses, individuals, and nonprofits. To learn more, visit www.ambassador-enterprises.com
HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined operating experience in healthcare as CEOs and investors. For more information on HealthEdge, visit www.healthedgepartners.com.
For more information, please contact Matt Dawson at HealthEdge Investment Partners at (813) 490-7100.